Photoimmunotherapy for Mesothelioma Reduces Tumor Volume in Mice
Japanese researchers testing photoimmunotherapy for mesothelioma say they used the technology to successfully reduce the size of tumors in mice.…
-
-
Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights
New research conducted by a team of German and Austrian scientists could help make personalized immunotherapy for mesothelioma possible. Mesothelioma… -
PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study
A study of the PD-L1 inhibitor nivolumab showed “safety and efficacy” in mesothelioma patients who failed with other treatments. Nivolumab… -
Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed
A new report says biomarkers are urgently needed to determine which patients would benefit from immunotherapy for pleural mesothelioma. Researchers… -
Immunotherapy Prompts “Remarkable Response” in Sarcomatoid Pleural Mesothelioma
Japanese doctors are reporting a remarkable response from the immunotherapy drug nivolumab in a patient with sarcomatoid pleural mesothelioma. Sarcomatoid… -
Amazing Keytruda Case Study Offers Hope for Advanced Mesothelioma
Italian doctors are reporting an “impressive clinical response” in a recently published Keytruda case study. The case is encouraging news… -
Immunotherapy with ONCOS-102 Shows Promise for Mesothelioma
Early results are in on the latest trial of immunotherapy with ONCOS-102 and the news is good for pleural mesothelioma… -
CRISPR Gene Editing Technique and the Future of Mesothelioma Treatment
The powerful CRISPR gene editing technique might have a role to play in the future of mesothelioma treatment. CRISPR is… -
Pembrolizumab for Mesothelioma Dealt Setback by New Trial Results
There has been a setback for researchers focused on the promise of pembrolizumab for mesothelioma. New research suggests that pembrolizumab… -
Mesothelioma Tumor Response to Nivolumab Detailed in New Case Study
An Indian woman in still alive two years after a mesothelioma diagnosis thanks to a remarkable mesothelioma tumor response to…
